KRYS

KRYSTAL BIOTECH INC

Data as of 2026 Q2 (06-30) · 13F snapshot

Summary

KRYSTAL BIOTECH INC (KRYS) is held as common stock by 4 tracked hedge-fund managers, with a combined reported value of ~$43.94M; the largest are Renaissance Technologies, Ray Dalio, Ken Griffin. 1 tracked manager also disclosed PUT or CALL positions, reported separately below. This quarter: 3 added, 2 closed. 4 public STOCK Act / OGE trade disclosures are on record. Data as of 2026 Q2, from public SEC 13F filings, delayed up to ~45 days.

Attention · MediumThis quarter · Mixed

Common-stock holders41 also report options

Congress trades4

Price$335.06vs quarter-end-9.85%

Sectors0

This quarter's moves

New0

Added3

Trimmed / sold2

Top holder

Renaissance Technologies

Common-stock positions

PUT and CALL disclosures are excluded from these holder counts and values.

Ken GriffinHold

Value $1.01M0.0% of portfolio2,7252026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken Griffin	2026 Q2	$1.01M	2,725	0.0%	Hold

PUT / CALL disclosures

Reported separately: 13F option values are not common-stock ownership and do not reveal the full strategy or economic exposure.

Ken GriffinCALL—

Value $13.57M— of portfolio36,5002026 Q2

Ken GriffinPUT—

Value $1.41M— of portfolio3,8002026 Q2

Investor	Period	Value	Shares	% of portfolio	Action
Ken GriffinCALL	2026 Q2	$13.57M	36,500	—	—
Ken GriffinPUT	2026 Q2	$1.41M	3,800	—	—

Public SEC 13F filings may appear up to 45 days after quarter-end; STOCK Act / OGE trade filings are generally due within 45 days but may be late. Partial data only — research, not investment advice.